Molecular Targets and Therapeutics Center
Institute of Radiation Medicine
The Institute of Radiation Medicine (IRM) at Helmholtz Munich encompassed all aspects of modern radiation research, with a focus on translational issues and clinical applications.
Our highly interdisciplinary team, comprising physicists, biologists, medical doctors, and engineers, aimed to integrate preclinical knowledge, theoretical modeling, and clinical practice in Clinical and Experimental Radiation Oncology, with a particular emphasis on radiotherapy research.
The IRM was closely associated with the Department of Radiation Oncology and Radiotherapy at Klinikum rechts der Isar (TUM) and the German Consortium for Translational Cancer Research (DKTK) at its partner location in Munich.
One focus was clinically oriented research on technical and biological issues of radiotherapy. This included research into preclinical radiation biology and molecular biology, imaging, and new technological developments in radiation technology, providing a solid basis for bridging the gap between preclinical knowledge, theoretical computations, and clinical application.
The Institute of Radiation Medicine was closed on December 31, 2025. This website serves as an archive of the institute’s research activities and scientific work.
The Institute of Radiation Medicine (IRM) at Helmholtz Munich encompassed all aspects of modern radiation research, with a focus on translational issues and clinical applications.
Our highly interdisciplinary team, comprising physicists, biologists, medical doctors, and engineers, aimed to integrate preclinical knowledge, theoretical modeling, and clinical practice in Clinical and Experimental Radiation Oncology, with a particular emphasis on radiotherapy research.
The IRM was closely associated with the Department of Radiation Oncology and Radiotherapy at Klinikum rechts der Isar (TUM) and the German Consortium for Translational Cancer Research (DKTK) at its partner location in Munich.
One focus was clinically oriented research on technical and biological issues of radiotherapy. This included research into preclinical radiation biology and molecular biology, imaging, and new technological developments in radiation technology, providing a solid basis for bridging the gap between preclinical knowledge, theoretical computations, and clinical application.
The Institute of Radiation Medicine was closed on December 31, 2025. This website serves as an archive of the institute’s research activities and scientific work.
Publications of Our Institute
Augustin, T. ; Oliinyk, D. ; Haderlein, M. ; Frei, C. ; Jacob, J. ; Medenwald, D. ; Trommer, M. ; Mäurer, M. ; Drozdz, S. ; Rühle, A. ; Grosu, A.L. ; Nicolay, N.H. ; Waltenberger, M. ; Combs, S.E. ; Löser, A. ; Oertel, M. ; Eich, H.T. ; Janssen, S. ; Rauch, J. ; Gurtner, R. ; Renollet, R. ; Spitzweg, C. ; Vordermark, D. ; Belka, C. ; Käsmann, L.
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC).Moser, R. ; Buchecker, L.M. ; Nano, J. ; Mayr, N.A. ; Behzadi, S.T. ; Kiesl, S. ; Maier, S. ; Allwohn, L. ; Lammert, J. ; Adams, L.C. ; Tschochohei, M. ; Combs, S.E. ; Borm, K.J.
Attitudes towards large language model-based AI systems as an information source for shared decision making in radiation oncology.Prucker, P. ; Bressem, K.K. ; Peeken, J.C. ; Jukic, M. ; Marka, A.W. ; Strenzke, M. ; Kim, S.H. ; Mertens, C.J. ; Weller, D.L. ; Lemke, T. ; Graf, M.M. ; Ziegelmayer, S. ; Kader, A. ; Lammert, J. ; Makowski, M.R. ; Busch, F.W. ; Adams, L.C.
A prospective controlled trial of large language model-based simplification of oncologic CT reports for patients with cancer.Leiss, S.M. ; Wiestler, B. ; Hou, H.X. ; Schmottermeyer, D. ; Sackerer, V. ; Diehl, C. ; Peeken, J.C. ; Borm, K. ; Negwer, C. ; Wagner, A. ; Yakushev, I. ; Delbridge, C. ; Mitsdörffer, M. ; Schmidt-Graf, F. ; Meyer, B. ; Combs, S.E. ; Bernhardt, D.
Comorbidity burden in elderly high-grade glioma patients: Impact on radiotherapy outcomes.Harrison, L. ; Schriever, S.C. ; Bernecker, M. ; Mallet, N. ; Mencias Castillejo, C. ; Ameli, H. ; Baumann, P. ; Contreras, R. ; Stolz, J. ; Lindner, R. ; Bartzsch, S. ; Schmid, T.E. ; Combs, S.E. ; Rosemann, M. ; Pfluger, P.T.
Low-to-moderate dosed cranial irradiation in young mice induces sex-specific metabolic disturbances later in life.